Network pharmacology as a platform for drug discovery for hypertrophic scars.

This article discusses the use of network pharmacology as a platform for drug discovery for hypertrophic scars. Hypertrophic scars are a type of abnormal wound healing that can cause disfigurement and impair functionality. Current treatment options are often ineffective, so novel approaches are needed. The study utilized network pharmacology to identify scar-associated genes and signaling pathways, and identified crizotinib as a promising treatment. The study also highlights the potential of computational modeling and experimental validation to identify new drugs and repurpose existing drugs. However, the study focused exclusively on hypertrophic scars and not keloids, which are often more severe and treatment resistant. Further research and clinical trials are needed to establish the safety and efficacy of new treatments for scars. [Extracted from the article]